Sphingosylphosphorylcholine is a proinflammatory mediator in cerebral arteries

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 1, 2011, Pages 212-221

  Wirrig, Christiane ^a   Hunter, Irene ^a   Mathieson, Fiona A ^a   Nixon, Graeme F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

cerebral artery; inflammation; sphingolipid; vasospasm

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSYLPHOSPHORYLCHOLINE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; BRAIN VASOSPASM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE;

ANIMALS; BLOOD PLATELETS; BLOTTING, WESTERN; CELLS, CULTURED; CEREBRAL ARTERIES; CHEMOKINE CCL2; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; INFLAMMATION; INFLAMMATION MEDIATORS; LYSOPHOSPHOLIPIDS; MALE; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLCHOLINE; RATS; RATS, SPRAGUE-DAWLEY; SPHINGOSINE; SUBARACHNOID HEMORRHAGE; TRANSCRIPTION FACTORS; UP-REGULATION; VASOSPASM, INTRACRANIAL;

EID: 78650917064     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.79     Document Type: Article

References (40)

1. Aihara Y, Kasuya H, Onda H, Hori T, Takeda J (2001) Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 32:212-7
2. Alewijnse AE, Peters SLM, Michel MC (2004) Cardiovascular effects of sphingosine 1-phosphate and other sphingomyelin metabolites. Br J Pharmacol 143:666-84
3. Bederson JB, Connolly Jr ES, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner Jr JE, Harbaugh RE, Patel AB, Rosenwasser RH (2009) American Heart Association Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40:994-1025
4. Coussin F, Scott RH, Nixon GF (2003) Sphingosine 1-phosphate induces CREB activation in rat cerebral artery via a protein kinase C-mediated inhibition of voltage-gated K+ channels. Biochem Pharmacol 66: 1861-70
5. Coussin F, Wise A, Scott RH, Nixon GF (2002) Comparison of sphingosine 1-phosphate-induced intracellular signalling pathways in vascular smooth muscle: differential role in vasoconstriction. Circ Res 91:151-7
6. Dumont, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS (2003) Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53:123-33
7. Dwarakanath RS, Sahar S, Reddy MA, Castanotto D, Rossi JJ, Natarajan R (2004) Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kB. J Mol Cell Cardiol 36:585-95
8. Gaetani P, Tartara F, Pignatti P, Tancioni F, Rodriguez y Baena R, De Benedetti F (1998) Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 20:337-42
9. Hayden MS, West AP, Ghosh S (2006) NF-kB and the immune response. Oncogene 25:6758-80
10. Hendryk S, Jarzab B, Josko J (2004) Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett 25:141-7
11. Ishii I, Ye X, Friedman B, Kawamura S, Contos JJ, Kingsbury MA, Yang AH, Zhang G, Brown JH, Chun J (2002) Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. J Biol Chem 277:25152-9
12. Kassell NF, Sasaki T, Colohan AR, Nazar G (1985) Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562-72
13. Kim GH, Kellner CP, Hahn DK, Desantis BM, Musabbir M, Starke RM, Rynkowski M, Komotar RJ, Otten ML, Sciacca R, Schmidt JM, Mayer SA, Connolly Jr ES (2008) Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 109:38-43
14. Kolias AG, Sen J, Belli A (2009) Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. J Neurosci Res 87:1-11
15. Kurokawa T, Yumiya Y, Fujisawa H, Shirao S, Kashiwagi S, Sato M, Kishi H, Miwa S, Mogami K, Kato S, Akimura T, Soma M, Ogasawara K, Ogawa A, Kobayashi S, Suzuki M (2009) Elevated concentrations of sphingosylphosphorylcholine in cerebrospinal fluid after subarachnoid hemorrhage: a possible role as a spasmogen. J Clin Neurosci 16:1064-8
16. Liliom K, Sun G, Bunemann M, Virag T, Nusser N, Baker DL, Wang DA., Fabian MJ, Brandts B, Bender K, Eickel A, Malik KU, Miller DD, Desiderio DM, Tigyi G, Pott L (2001) Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. Biochem J 355:189-97
17. Lu H, Shi JX, Chen HL, Hang CH, Wang HD, Yin HX (2009) Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage. Brain Res 1262:73-80
18. Macdonald RL, Weir BK (1991) A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-82
19. Macdonald RL, Weir BK, Runzer TD, Grace MG, Findlay JM, Saito K, Cook DA, Mielke BW, Kanamaru K (1991) Etiology of cerebral vasospasm in primates. J Neurosurg 75:415-24
20. Maddahi A, Edvinsson L (2010) Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. J Neuroinflammation 7:14
21. Mathieson FA, Nixon GF (2006) Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle. Br J Pharmacol 147:351-9
22. Meyer zu Heringdorf D, Himmel HM, Jakobs KH (2002) Sphingosylphosphorylcholine-biological functions and mechanisms of action. Biochem Biophys Acta 1582:178-89
23. Mocco J, Zacharia BE, Komotar RJ, Connolly Jr ES (2006) A review of current and future medical therapies for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurosurg Focus 21:E9
24. Nishizawa S, Laher I (2005) Signalling mechanisms in cerebral vasospasm. Trends Cardiovasc Med 15:24-34
25. Nixon GF, Mathieson FA, Hunter I (2008) The multifunctional role of sphingosylphosphorylcholine. Prog Lipid Res 47:62-75
26. Okajima F (2002) Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim Biophys Acta 1582:132-7
27. Onda H, Kasuya H, Takakura K, Hori T, Imaizumi T, Takeuchi T, Inoue I, Takeda J (1999) Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 19:1279-88
28. Saklatvala J (2004) The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol 4:372-7
29. Sanchez T, Hla T (2004) Structural and functional characteristics of S1P receptors. J Cell Biochem 92: 913-22
30. Schoch B, Regel JP, Wichert M, Gasser T, Volbracht L, Stolke D (2007) Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage. Neurosurgery 60:828-36
31. Sehba FA, Bederson JB (2006) Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res 28:381-98
32. Sekine O, Nishio Y, Egawa K, Nakamura T, Maegawa H, Kashiwagi A (2002) Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. J Biol Chem 277:36631-9
33. Shirao S, Kashiwagi S, Sato M, Miwa S, Nakao F, Kurokawa T, Todoroki-Ikeda N, Mogami K, Mizukami Y, Kuriyama S, Haze K, Suzuki M, Kobayashi S (2002) Sphingosylphosphorylcholine is a novel messenger for Rho-kinasemediated Ca2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C. Circ Res 91:112-9
34. Thomas GD, Snetkov VA, Patel R, Leach RM, Aaronson PI, Ward JP (2005) Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: activation of nonstore-operated Ca2+ entry. Cardiovasc Res 68:56-64
35. Tosaka M, Okajima F, Hashiba Y, Saito N, Nagano T, Watanabe T, Kimura T, Sasaki T (2001) Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke 32:2913-9
36. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T (1997) Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kB sites and NF-kB/Rel subunit specificity. J Biol Chem 272:31092-9
37. Vikman P, Ansar S, Edvinsson L (2007) Transcriptional regulation of inflammatory and extracellular matrixregulating genes in cerebral arteries following experimental subarachnoid hemorrhage in rats. Laboratory investigation. J Neurosurg 107:1015-22
38. Waldsee R, Ahnstedt H, Eftekhari S, Edvinsson L (2010) Involvement of calcium-calmodulin-dependent protein kinase II in endothelin receptor expression in rat cerebral arteries. Am J Physiol Heart Circ Physiol 298:H823-32
39. Yatomi Y (2008) Plasma sphingosine 1-phosphate metabolism and analysis. Biochim Biophys Acta 1780:606-11
40. Yatomi Y, Ruan F, Hakomori S, Igarashi Y (1995) Sphingosine 1-phosphate: a platelet-activating sphingolipid released from stimulated human platelets. Blood 86: 193-202